In 1993, Sikiric and colleagues in Zagreb isolated a cytoprotective protein from human gastric juice, called Body Protection Compound (BPC), whose fragment 157 (15 amino acids) reproduces most of its regenerative activity
Ingredient-Level Evidence: What the Research Actually Says Each ingredient in the formula carries a distinct evidence profile
Clinical Status: BPC-157 is a research peptide evaluated in numerous animal models and limited human observational studies for gastrointestinal healing, musculoskeletal regeneration, and angiogenic modulation
Tesamorelin: A Growth Hormone-Releasing Factor Analogue for HIV-Associated Lipodystrophy
Subcutaneous injection into the tissue adjacent to the tendon delivers high local concentration while allowing systemic distribution
Contraindications: Not for use in individuals with cancer, during pregnancy/breastfeeding, or those under 18